Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renshen + Huangjing (人参黄精液) is a Traditional Chinese Medicine (TCM) oral liquid developed and marketed by Conchen Pharmaceutical, a subsidiary of the Consun Pharmaceutical Group. This formulation is a combination of two primary herbal ingredients: Ginseng (Renshen) and Polygonatum (Huangjing). It is primarily indicated as a health tonic to replenish vital energy (Qi), nourish Yin, and support general physical well-being. Ginseng is traditionally used for its adaptogenic properties to enhance physical and mental stamina, while Polygonatum is used to moisten the lungs and strengthen the kidneys and spleen. The product is approved in China and is part of Conchen's wellness and tonic product line, typically administered as an oral solution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on renshen + huangjing.